AXIM - AXIM Biotechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue47.57347.05949.139
Cost of Revenue42.857154.1350.387
Gross Profit4.716-107.071-1.248
Operating Expenses
Research Development1,352.969235.579571.455
Selling General and Administrative1,797.4783,413.4569,475.724
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-3,149.087-3,759.462-10,049.546
Income from Continuing Operations
Total Other Income/Expenses Net-704.103-1,774.71-1,774.71
Earnings Before Interest and Taxes-3,853.19-5,534.172-10,049.546
Interest Expense315.013275.73443.221
Income Before Tax-4,168.203-5,809.906-10,092.767
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-4,168.203-5,809.906-10,092.767
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-4,168.203-5,809.906-10,092.767
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-4,168.203-7,284.906-10,092.767